References
- Ball P. Infective pathogenesis and outcomes in chronic bronchitis. Curr Opin Pulm Med 1996; 2: 181–185.
- Cazzola M. Problems and prospectives in the antibiotic treatment of lower respiratory tract infections. Pulm Pharmacol 1994; 7: 139–152.
- Anthonisen NR, Manfreda J, Warren CPW, Hershfeild ES, Harding GKM, Nelson NA. Antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196–204.
- Allegra L, Grassi C, Grossi E, Pozzi E. Ruolo degli antibiotici nel trattamento della riacutizzazione della bron-chite cronica. G It Mal Tor 1991; 45: 138–148.
- Saint S, Bent S, Vittinghof E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations. JAMA 1995; 273: 957–960.
- Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pul-monary disease (COPD). Eur Respir J 1995; 8: 1398–1420.
- Cazzola M, Diamare F, Di Perna F, Allegra L. 11 ruolo degli inibitori delle 13-lattamasi nelle infezioni del tratto respi-ratorio inferiore. Rass Pat App Respir 1996; 11: 26-39. Westerberg SC, Smith CB, Renzetti AD. Mycoplasma infections in patients with chronic obstructive pulmonary dis-ease. J Infect Dis 1973; 127: 491–497.
- Cosentini R, Blasi F. New pathogens for respiratory infections. Curr Opin Pulm Med 1996; 2: 174–180.
- Balter MS. Recommendations on the management of chronic bronchitis. Can Med Ass J 1994; 151 (Suppl): 1-23.
- Sides GD, Cerimele BJ, Black HR, Busch U, DeSante KA. Pharmacokinetics of dirithromycin. J Antimicrob Chemother 1993; 31 (Suppl C): 65-75.
- DeSante KA. Human pharmacokinetics and bioavail-ability of dirithromycin. Drugs Today 1995; 31 (Suppl C): 11-16.
- Bergogne-Berezin E. Tissue distribution of dirithromycin: comparison with erythromycin. J Antimicrob Chemother 1993; 31 (Suppl C): 77-87.
- Cazzola M. Pulmonary pharmacokinetics of dirithromycin allow a 5-day treatment of acute bacterial exac-erbation of chronic bronchitis. Drugs Today 1995; 31 (Suppl. C): 17-21.
- Matera MG, Tufano MA, Polverino M, Rossi F, Cazzola M. Pulmonary concentrations of dirithromycin and erythromycin during acute exacerbation of mild chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 97–102.
- Sides GD. Clinical efficacy of dirithromycin in acute exacerbation of chronic bronchitis. J Antimicrob Chemother 1993; 31 (Suppl C): 131-138.
- Gaillat J. A multicentre study comparing the safety and efficacy of dirithromycn with erythromycin in the treatment of bronchitis. J Antimicrob Chemother 1993; 31 (Suppl C): 139-151.
- Pozzi E. Clinical efficacy of dirithromycin versus mio-camycin in acute exacerbation of chronic bronchitis. J Antimicrob Chemother 1993; 31 (Suppl C): 153-158.
- Cazzola M, Matera MG, Tufano MA, Polverino M, Catalanotti P, Varanese L, Rossi F. Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis. Pulm Pharmacol 1994; 7: 377–381.
- Ball P, Harris JM, Lowson D, Tillotson G, Wilson R. Acute infective exacerbations of chronic bronchitis. Q J Med 1991; 88: 61–68.
- Chodosh S. Examination of sputum cells. N Engl J Med 1970; 282: 854–857.
- National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bac-teria that grow aerobically. 2nd ed. Approved standard M7 A2. Villanova, PA: NCCLS, 1990.
- Lode H, Boeckh M, Schaberg T. Human pharmacoki-netics of macrolide antibiotics. In: Bryskier AJ, Butzler J-P, Neu HC, Tulkens PM, eds. Macrolides. Chemistry, pharma-cology and clinical uses. Paris: Arnette-Blackwell, 1993: 409–420.
- Neu HC. Activity of macrolides against common pathogens in vitro. In: Bryskier AJ, Butzler J-P, Neu HC, Tulkens PM, eds. Macrolides. Chemistry, pharmacology and clinical uses. Paris: Arnette-Blackwell, 1993: 167–182.
- Derriennic M. Antimicrobial activity of dirithromycin. Drugs Today 1995; 31 (suppl C): 23-28.
- Leroyer C, Boussac J, Lode H, Smits JPH, Sides G. A comparison of 5 days of dirithromycin and 7 days of rox-ithromycin in acute bacterial exacerbation of chronic bronchi-tis. Immunol Infect Dis 1995; 5: 149–155.
- Hosie J, Quinn P, Smits P, Sides G. A comparison of 5 days of dirithromycin and 7 days of clarithromycin in acute bacterial exacerbation of chronic bronchitis. J Antimicrob Chemother 1995; 36: 173–183.
- Schito GC, Grazi G, Dainelli B, et al. Incidence of lower tract infections caused by mycoplasma, chlamydia and Legionella: an Italian multicenter survey. J Chemother 1994; 6: 319–321.
- Bergogne-Berezin E, Stotka JL. Clinical studies of dirithromycin. Drugs Today 1995; 31 (suppl C): 29-36.